Lobbying client

VIAL HEALTH TECHNOLOGY INC.

Biotech

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
14
Filed by
3
Reported in-house
—
Reported by firms
$1,050,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ millions 2025 to 2026

Filings

14 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination
1st Quarter 2026
MILLER STRATEGIES, LLC — reported
1st Quarter - Termination
1st Quarter 2026
VIAL HEALTH TECHNOLOGY, INC. — reported
4th Quarter - Termination
4th Quarter 2025
TODD STRATEGY GROUP $90,000 reported
4th Quarter - Report
4th Quarter 2025
VIAL HEALTH TECHNOLOGY, INC. $280,000 reported
4th Quarter - Reportreplaced
4th Quarter 2025
TODD STRATEGY GROUP $90,000 reported
4th Quarter - Report
4th Quarter 2025
MILLER STRATEGIES, LLC $50,000 reported
3rd Quarter - Report
3rd Quarter 2025
TODD STRATEGY GROUP $90,000 reported
2nd Quarter - Report
2nd Quarter 2025
TODD STRATEGY GROUP $90,000 reported
3rd Quarter - Report
3rd Quarter 2025
MILLER STRATEGIES, LLC $150,000 reported
3rd Quarter - Report
3rd Quarter 2025
VIAL HEALTH TECHNOLOGY, INC. $280,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
VIAL HEALTH TECHNOLOGY, INC. 3 $560,000
TODD STRATEGY GROUP 3 $270,000
MILLER STRATEGIES, LLC 4 $220,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 13

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.